Ursofalk maka ọrịa imeju na gallbladder

Ndinaya
Ursofalk bụ ọgwụ egosiri maka mgbasa nke nkume na gallbladder ma ọ bụ ọrịa ndị ọzọ nke gallbladder, ọgwụgwọ nke biliary cirrhosis mbụ, ọgwụgwọ nke mgbaze na-adịghị mma na mgbanwe qualitative na bile, n'etiti ndị ọzọ.
Uzo a nwere ursodeoxycholic acid, nke bu ihe omuma nke di na mmadu bile, obu ezie na onu ogugu. Acid a na - egbochi njikọ cholesterol n'ime imeju ma na - akpali njikọ nke acid bile, na - eweghachite nguzozi n'etiti ha. Na mgbakwunye, ọ na-esokwa na solubilization nke cholesterol site na bile, na-egbochi guzobe gallstones ma ọ bụ na-akwado mgbasa ha.

Gịnị ka ọ bụ maka
Ursodeoxycholic acid bu ihe ngosiputa egosiputara maka oria nke imeju, gallbladder na bile duct, n ’onodu ndia:
- Gallstones guzobere site na cholesterol na ụfọdụ ndị ọrịa;
- Mgbaàmà nke isi biliary cirrhosis;
- Nkịtị fọdụrụ na ọwa gallbladder ma ọ bụ nkume ọhụụ e guzobere mgbe a wachara ya ahụ nke eriri afọ bile;
- Mgbaàmà nke mgbaze na-adịghị mma, dị ka ihe mgbu afọ, obi mgbu na izu ezu, kpatara ọrịa nke gallbladder;
- Ngbanwe nke ịrụ ọrụ nke mmiri cystic ma ọ bụ gallbladder na syndromes metụtara;
- Akwa cholesterol ma obu triglycerides;
- Na-akwado ọgwụgwọ na mgbasa nke gallstones site na ebili mmiri, nke cholesterol guzobere na ndị ọrịa nwere cholelithiasis;
- Ogo na ọnụọgụ na-agbanwe na bile.
Mara otu esi amata ihe mgbaàmà nke gallstones.
Esi ewere
Ursofalk kwesiri ichoputa ndi ogwu.
Maka iji oge dị ogologo, iji gbochie nguzobe nkume, nkezi onunu ogwu bụ 5 ka 10 mg / kg / ụbọchị, nkezi onunu ogwu bụ, n'ọtụtụ ọnọdụ, n'etiti 300 ruo 600 mg, kwa ụbọchị, maka opekata mpe ọnwa 4 ruo 6, ma nwee ike iru ọnwa iri na abụọ ma ọ bụ karịa. Ọgwụgwọ ekwesịghị ịgafe afọ abụọ.
N'ọrịa syndromes na ọgwụgwọ mmezi, usoro nke 300 mg kwa ụbọchị zuru oke, kewara n'ime 2 gaa na 3 nchịkwa, agbanyeghị dọkịta a nwere ike gbanwee ya.
Na ndị ọrịa na-agwọ ọgwụgwọ maka nsị gallstone, ọ dị mkpa ịlele irè ursodeoxycholic acid, site na nyocha cholecystographic, kwa ọnwa isii.
N'ime ọgwụgwọ ọzọ nke mkpofu mmiri nke gallstones, ọgwụgwọ gara aga na ursodeoxycholic acid na-abawanye nsonaazụ nke ọgwụgwọ. Ekwesịrị ịhazi doses nke ursodeoxycholic acid, na-ebute 600 mg kwa ụbọchị.
Na isi biliary cirrhosis, doses nwere ike ịdị iche site na 10 ruo 16 mg / kg / ụbọchị, dịka ọkwa nke ọrịa ahụ. A na-atụ aro ka ị nyochaa ndị ọrịa site na nyocha ọrụ imeju na bilirubin mmesho.
Ekwesịrị inye ọgwụ ọgwụ kwa ụbọchị 2 ma ọ bụ 3 ugboro, dabere na ngosipụta eji, mgbe nri.
Omume puru omume
Mmetụta kachasị emetụta nke nwere ike ime n'oge ọgwụgwọ Ursofalk bụ agbanwe agbanwe nke oche, nke nwere ike ịghọ ihe gara aga, ma ọ bụ afọ ọsịsa.
Onye na-ekwesịghị iji
Ejila ursofalk mee ihe nfụkasị ursodeoxycholic acid ma ọ bụ ihe ọ bụla nke usoro ahụ, ndị nwere ọnya na-arụsi ọrụ ike, ọrịa obi na-afụ ụfụ na ọnọdụ ndị ọzọ nke obere eriri afọ, eriri afọ na imeju, nke nwere ike igbochi nsị enterohepatic bile salts , Ugboro biliary colic, nnukwu mbufụt nke gallbladder ma ọ bụ biliary tract, biliary tract occlusion, mebiri gallbladder contractility ma ọ bụ radiopaque calcified gallstones.
Tụkwasị na nke a, ụmụ nwanyị dị ime agaghị eji ọgwụ a eme ihe na-enweghị ndụmọdụ ahụike.